Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil: A cross-sectional study and the implications

Thannuse Silva Athie; Gesiane Cavalcante Nascimento; Maria José Labis Da Costa; Juliana De Sales Silva; Edna Afonso Reis; Antony Paul Martin; Brian Godman; Isabella Piassi Dias Godoí

doi:10.2217/cer-2020-0241

Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil: A cross-sectional study and the implications

Thannuse Silva Athie, Gesiane Cavalcante Nascimento, Maria José Labis Da Costa, Juliana De Sales Silva, Edna Afonso Reis, Antony Paul Martin, Brian Godman, Isabella Piassi Dias Godoí^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

Aim: Chagas disease is a serious public health problem, endemic in 21 countries in Latin America. A future vaccine can contribute to decreasing the number of cases and its complications. Methods: A cross-sectional study was conducted with residents of the northern region of Brazil, on the willingness to pay for a hypothetical vaccine against Chagas disease (effective protection of 80%). Results: We interviewed 619 individuals and seven were excluded from the analysis and the value of willingness to pay was US$23.77 (100.00 BRL). Conclusion: The Northern region of Brazil is one of the largest markets for this vaccine, due to its epidemiological relevance, so economic studies with this vaccine will be important to assist in the assessment of technologies.

Original language	English
Pages (from-to)	659-672
Number of pages	14
Journal	Journal of Comparative Effectiveness Research
Volume	10
Issue number	8
DOIs	https://doi.org/10.2217/cer-2020-0241
Publication status	Published - Jun 2021
Externally published	Yes

Keywords

Brazil
Chagas disease
contingent valuation
vaccine
willingness to pay

Access to Document

10.2217/cer-2020-0241

Cite this

@article{a01aaa30f1224103b66700be02214b5d,

title = "Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil: A cross-sectional study and the implications",

abstract = "Aim: Chagas disease is a serious public health problem, endemic in 21 countries in Latin America. A future vaccine can contribute to decreasing the number of cases and its complications. Methods: A cross-sectional study was conducted with residents of the northern region of Brazil, on the willingness to pay for a hypothetical vaccine against Chagas disease (effective protection of 80%). Results: We interviewed 619 individuals and seven were excluded from the analysis and the value of willingness to pay was US$23.77 (100.00 BRL). Conclusion: The Northern region of Brazil is one of the largest markets for this vaccine, due to its epidemiological relevance, so economic studies with this vaccine will be important to assist in the assessment of technologies.",

keywords = "Brazil, Chagas disease, contingent valuation, vaccine, willingness to pay",

author = "Athie, {Thannuse Silva} and Nascimento, {Gesiane Cavalcante} and {Da Costa}, {Maria Jos{\'e} Labis} and {De Sales Silva}, Juliana and Reis, {Edna Afonso} and Martin, {Antony Paul} and Brian Godman and Godo{\'i}, {Isabella Piassi Dias}",

year = "2021",

month = jun,

doi = "10.2217/cer-2020-0241",

language = "English",

volume = "10",

pages = "659--672",

journal = "Journal of Comparative Effectiveness Research",

issn = "2042-6305",

publisher = "Becaris Publishing Ltd",

number = "8",

}

Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil: A cross-sectional study and the implications. / Athie, Thannuse Silva; Nascimento, Gesiane Cavalcante; Da Costa, Maria José Labis et al.
In: Journal of Comparative Effectiveness Research, Vol. 10, No. 8, 06.2021, p. 659-672.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil

T2 - A cross-sectional study and the implications

AU - Athie, Thannuse Silva

AU - Nascimento, Gesiane Cavalcante

AU - Da Costa, Maria José Labis

AU - De Sales Silva, Juliana

AU - Reis, Edna Afonso

AU - Martin, Antony Paul

AU - Godman, Brian

AU - Godoí, Isabella Piassi Dias

PY - 2021/6

Y1 - 2021/6

N2 - Aim: Chagas disease is a serious public health problem, endemic in 21 countries in Latin America. A future vaccine can contribute to decreasing the number of cases and its complications. Methods: A cross-sectional study was conducted with residents of the northern region of Brazil, on the willingness to pay for a hypothetical vaccine against Chagas disease (effective protection of 80%). Results: We interviewed 619 individuals and seven were excluded from the analysis and the value of willingness to pay was US$23.77 (100.00 BRL). Conclusion: The Northern region of Brazil is one of the largest markets for this vaccine, due to its epidemiological relevance, so economic studies with this vaccine will be important to assist in the assessment of technologies.

AB - Aim: Chagas disease is a serious public health problem, endemic in 21 countries in Latin America. A future vaccine can contribute to decreasing the number of cases and its complications. Methods: A cross-sectional study was conducted with residents of the northern region of Brazil, on the willingness to pay for a hypothetical vaccine against Chagas disease (effective protection of 80%). Results: We interviewed 619 individuals and seven were excluded from the analysis and the value of willingness to pay was US$23.77 (100.00 BRL). Conclusion: The Northern region of Brazil is one of the largest markets for this vaccine, due to its epidemiological relevance, so economic studies with this vaccine will be important to assist in the assessment of technologies.

KW - Brazil

KW - Chagas disease

KW - contingent valuation

KW - vaccine

KW - willingness to pay

UR - http://www.scopus.com/inward/record.url?scp=85105913131&partnerID=8YFLogxK

U2 - 10.2217/cer-2020-0241

DO - 10.2217/cer-2020-0241

M3 - Article

C2 - 33851872

AN - SCOPUS:85105913131

SN - 2042-6305

VL - 10

SP - 659

EP - 672

JO - Journal of Comparative Effectiveness Research

JF - Journal of Comparative Effectiveness Research

IS - 8

ER -

Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil: A cross-sectional study and the implications

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this